Switching from OpenLoop or Bask? Free white-glove migration in days.
PharmaBro
  1. Home
  2. Blog
  3. Platform comparison
Platform comparison

Cuvo vs Rimo

Both refuse the revenue share, both publish pricing, both launch fast. The decision comes down to whether you want the clinic operated for you, and who holds the merchant account.

Anmol SethiFounder4 min read

Key takeaways

  • Both are flat-fee, both publish pricing, and both handle LegitScript. That already filters out most of the category.
  • Cuvo is done-for-you: the clinic is operated on your behalf, and Cuvo is merchant of record.
  • Rimo is bring-your-own: the brand owns its Stripe account and operates the clinic itself.
  • Rimo has the longer flat-fee operator track record, largely via word of mouth.
  • Both limit brands per account, which matters for portfolio operators.
01

What they agree on

It is worth starting here, because agreement between two independent platforms on these points is a useful signal about what the category norm should be.

Both charge flat fees rather than a percentage of billings. Both publish pricing rather than gating it behind a discovery call. Both manage LegitScript rather than leaving the operator to file it. Both operate licensed providers across all 50 states with real compounding pharmacy networks behind them.

If your shortlist is these two, you have already filtered out the revenue-share model and the no-public-pricing model, which is most of the work.

02

The real difference: who operates the clinic

Cuvo sells a done-for-you operation. They run the clinic on your behalf, which means owning the clinical queue, the escalations and the pharmacy relationships day to day. In that model Cuvo acting as merchant of record is coherent: they are running the billing because they are running the operation.

Rimo sells infrastructure you operate. The brand connects its own Stripe account, holds the payment relationship, and runs the clinic itself with Rimo underneath.

This is not a quality difference. It is a difference in what job you are hiring the platform to do, and the merchant-of-record position follows from it rather than being an independent choice.

03

Where each is stronger

Both have genuine advantages worth naming specifically.

CuvoRimo
Pricing modelFlat, publishedFlat, published
Revenue shareNoneNone
Merchant of recordCuvoYour brand
Operating modelDone-for-youYou operate
LegitScriptManagedManaged, 7 to 14 days
Track record in flat feeStrong70+ brands, largely word of mouth
Brands per accountLimited by planLimited
LaunchFastAbout 5 days
04

Which one to choose

Choose Cuvo if you want to be a brand owner rather than an operator. If the appeal is that somebody else owns the clinical queue and the pharmacy relationships day to day, that is exactly what Cuvo sells and they sell it well. Accept in exchange that the merchant account, and therefore the stored card tokens, sit with them.

Choose Rimo if you intend to operate, want the payment relationship in your own name, and value a long flat-fee track record. Rimo's operator base arriving largely by word of mouth is a meaningful signal, because it is the one referral source that cannot be bought.

05

The constraint both share

Both limit how many brands you can run from one account. For a single-brand operator that is irrelevant. For a portfolio operator running weight management, testosterone and hair as separate brands, it means multiple contracts and multiple bills.

That is the question to press on with both: how many brands, on which plan, and what does the second one cost.

06

The third option, disclosed

This page is published by PharmaBro, a competitor to both. Read the following accordingly.

PharmaBro sits closest to Rimo structurally: flat published fee, brand-owned Stripe, no revenue share, LegitScript included, 5-day launch. The differences are unlimited brands on one account at every tier, no contract term, and an in-house rebill engine that bills on the ship date at the dose dispensed rather than using Stripe's recurring object.

Where Rimo is stronger: a longer operator track record in this specific model. That is real and we are not going to argue with it.

Where PharmaBro fits

If your shortlist is these two, you already agree with us

Choosing between Cuvo and Rimo means you have already rejected the revenue share and the unpublished price. The remaining questions are who holds the merchant account, how many brands one contract covers, and what happens to a failed payment.

Published pricing. Your own Stripe on every tier. Unlimited brands. No contract term.

Conclusion

Cuvo and Rimo represent the two honest answers to the same question, and the choice between them is genuinely about what you want to do yourself.

Done-for-you with the platform holding billing, or infrastructure with the brand holding it. Decide that first, and the rest of the comparison resolves itself.

Frequently asked questions

Are Cuvo and Rimo both flat fee?

Yes. Both charge flat platform fees rather than a percentage of patient billings, and both publish their pricing. That combination is rarer in this category than it should be.

Which one lets me keep my own Stripe account?

Rimo. The brand connects its own Stripe and holds the payment relationship. Cuvo operates as merchant of record, which is consistent with its done-for-you model but means the stored card tokens sit with them.

Can I run several brands on either?

Both limit brands per account, so a portfolio operator should ask specifically how many are included on which plan and what an additional brand costs. This is the constraint most likely to matter at brand two.

References

  1. 1.Cuvo published pricing
  2. 2.Rimo published pricing
  3. 3.LegitScript certification requirements

Every figure above is sourced and dated. If you represent one of the platforms named here and something is out of date or wrong, write to support@pharmabro.co and we will correct it and note the change on the page.

Written by

Anmol SethiFounder

Ran direct-to-consumer telehealth brands and paid a revenue share on every dollar they earned. Built PharmaBro as the infrastructure he wanted to buy.